43
Views
18
CrossRef citations to date
0
Altmetric
Research Article

Neurobiological aspects of suicidal behaviour

&
Pages 62-74 | Published online: 11 Jul 2009

References

  • ABBAR, M., COURTET, P., AMADEO, S., CAER, Y., MALLET, J., BALDY-MOULINIER, M., CASTELNAU, D. & MALAFOSSE, A. (1995). Suicidal behaviors and the tryptophan hydroxy-lase gene. Archives of General Psychiatry, 52, 846-849.
  • AGREN, H. (1980). Symptom patterns in unipolar and bipolar depression correlating with monoamine metabolites in the cerebrospinal fluid: II. Suicide. Psychiatry Research, 3, 225-236.
  • AGREN, H. (1983). Life at risk: markers of suicidality in depression. Psychiatric Developments, 1, 87-103.
  • ALVAREZ, J.C., CREMNITER, D., LESIEUR, P., GREGOIRE, A., GILTON, A., MACQUIN-MAVIER, I., JARREAU, C. & SPREUX-VAROQUAUX, O. (1999). Low blood cholesterol and low platelet serotonin levels in violent suicide attempters. Biological Psychiatr y, 45, 1066-1069.
  • ANGST, J. & CLAYTON, P. (1986). Premorbid personality of depressive, bipolar, and schizophrenic patients with special reference to suicidal issues. Comprehensive Psychiatry, 27, 511-532.
  • ASBERG, M. (1997). Neurotransmitters and suicidal behaviour.The evidence from cerebrospinal fluid studies. In: D.M. STOFF, & J.J. MANN (Eds), The neurobiology of suicide from the bench to the clinic (pp. 158-181. New York: New York Academy of Sciences.
  • ASBERG, M., BERTILSSON, L., MARTENSSON, B., SCALIA-TOMBA, G.P., THOREN, P. & TRASKMAN-BENDZ, L. (1984). CSF monoamine metabolites in melancholia. Acta Psychi-atrica Scandinavica, 69, 201-219.
  • ASBERG, M., TRASKMAN, L. & THOREN, P. (1976). 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? Archives of General Psychiatry, 33, 1193-1197.
  • ASHTON, C.H., MARSHALL, E.F., HASSANYEH, F., MARSH, V.R. et al. (1994). Biological correlates of deliberate self-harm behaviour: a study of electroencephalographic, biochemical and psychological variables in parasuicide. Acta Psychiatrica Scandinavica, 90, 316-323.
  • AYUSO-GUTIERREZ, J.L., CABRANES, J.A., GARCIA-CAMBA, E. & ALMOGUERA, I. (1987). Pituitary-adrenal disinhibition and suicide attempts in depressed patients. B iological Psychiatry, 22, 1409-1412.
  • BANKI, C.M. & ARATO, M. (1983a). Amine metabolites, neuroendocrine ndings, and personality dimensions as correlates of suicidal behavior. Psychiatry Research, 10, 253-261.
  • BANKI, C.M. & ARATO, M. (1983b). Relationship between cerebrospinal fluid amine metabolites, neuroendocrine ndings and personality dimensions (Marke-Nyman scale factors) in psychiatric patients. Acta Psychiatrica Scandi-navica, 67, 272-280.
  • BARRACLOUGH, B.M. (1987). The suicide rate of epilepsy. Acta Psychiatrica Scandinavica, 76, 339-345.
  • BECK, A.T., WEISSMAN, A., LESTER, D. & TREXLER, L. (1974). The measurement of pessimism: the hopelessness scale. Journal of Consulting and Clinical Psychology, 42, 861-865.
  • BELFRAGE, H., LIDBERG, L., MATTILA, M., BERTILSSON, L. & ASBERG, M. (in press). Suicide attempts and impulse control disorder are related to CSF 5-HIAA in mentally disordered violent offenders. Acta Psychiatrica Scandi-navica.
  • BELLIVIER, F., LEBOYER, M., COURTET, P., BURESI, C., BEAU-FILS, B., SAMOLYK, D., ALLILAIRE, J.F., FEINGOLD, J., MALLET, J. & MALAFOSSE, A. (1998). Association between the tryp-tophan hydroxylase gene and manic-depressive illness. Archives of General Psychiatry, 55, 33-37.
  • BERGMAN, B. & BRISMAR, B. (1994). Hormone levels and personality traits in abusive and suicidal male alcoholics. Alcoholism, Clinical & Experimental Research, 18, 311-316.
  • BERRETTINI, W.H., NURNBERGER, J.I., JR., NARROW, W., SIMMONS-ALLING, S. & GERSHON, E.S. (1986). Cerebrospinal fluid studies of bipolar patients with and without a history of suicide attempts. Annals of the NewYork Academy of Sciences, 487, 197-201.
  • BIEGON, A., GRINSPOON, A., BLUMENFELD, B., BLEICH, A., APTER, A. & MESTER, R. (1990). Increased serotonin 5-HT2 receptor binding on blood platelets of suicidal men. Psychopharmacology, 100, 165-167.
  • BIOULAC, B., BENEZECH, M., RENAUD, B., NOEL, B. & ROCHE, D. (1980). Serotoninergic dysfunction in the 47, XYY syndrome. Biological Psychiatry, 15, 917-923.
  • BLAND, R. & ORN, H. (1986). Family violence and psychiatric disorder. Canadian Journal of Psychiatry, 31, 129-137.
  • BOTSIS, A.J., SOLDATORS, C.R., LIOSSI, A., KOKKEVI, A. et al. (1994). Suicide and violence risk: I. Relationship to coping styles. Acta Psychiatrica Scandinavica, 89, 92-96.
  • BREWERTON, T.D., BERRETTINI, W.H., NURNBERGER, J.I., JR. & LINNOILA, M. (1988). Analysis of seasonal fluctuations of CSF monoamine metabolites and neuropeptides in normal controls: ndings with 5HIAA and HVA. Psychiatry Research, 23, 257-265.
  • BROWN, G.L., EBERT, M.H., GOYER, P.F., JIMERSON, D.C., KLEIN, W.J., BUNNEY, W.E. & GOODWIN, F.K. (1982). Aggression, suicide, and serotonin: relationships to CSF amine metabolites. American Journal of Psychiatry, 139, 741-746.
  • BROWN, R.P., MASON, B., STOLL, P., BRIZER, D., KOCSIS, J., STOKES, P.E. & MANN, J.J. (1986). Adrenocortical function and suicidal behavior in depressive disorders. Psychiatry Research, 17, 317-323.
  • BUNNEY, W.E., JR. & FAWCETT, J.A. (1965). Possibility of a biochemical test for suicidal potential. Archives of General Psychiatry, 13, 232-239.
  • CARLSSON, A., SVENNERHOLM, L. & WINBLAD, B. (1980). Seasonal and circadian monoamine variations in human brains examined post mortem. In: T.H. SVENSSON & A. CARLSSON (Eds) Biogenic amines and affective disorders. Acta Psychiatrica Scandinavica, 61, (Suppl. 280), 75-8.
  • CARROLL, B., GREDEN, J. & FEINBERG, M. (1981). Suicide, neuroendocrine dysfunction and CSF 5-HIAA concentrations in depression. In: B.ANGRIST, G. BURROWS, M. LADER, O. LINGJ RDE, G. SEDVALL & D. WHEATLEY (Eds), Recent advances in neuropsychopharmacology (pp. 307-313. New York: Pergamon Press.
  • CARROLL, B.J. (1982). The dexamethasone suppression test for melancholia. British Journal of Psychiatry, 140, 292-304.
  • CHOTAI, J., KULLGREN, G. & ASBERG, M. (1998). CSF monoamine metabolites in relation to the diagnostic interview for borderline patients (DIB). Neuropsychobi-ology, 38, 207-212.
  • CLEARE, A.J., MURRAY, R.M. & O’KEANE, V. (1996). Reduced prolactin and cortisol responses to d-fenfluramine in depressed compared to healthy matched control subjects. Neuropsychopharmacology, 14, 349-354.
  • CLONINGER, C.R. (1986). A uni ed biosocial theory of personality and its role in the development of anxiety states. Psychiatric Developments, 3, 167-226.
  • COCCARO, E.F., KAVOUSSI, R.J., TRESTMAN, R.L., GABRIEL, S.M., COOPER, T.B. & SIEVER, L.J. (1997). Serotonin function in human subjects: intercorrelations among central 5-HT indices and aggressiveness. Psychiatry Research, 73, 1-14.
  • COCCARO, E.F., SIEVER, L.J., KLAR, H.M., MAURER, G. et al. (1989). Serotonergic studies in patients with affective and personality disorders: correlates with suicidal and impulsive aggressive behavior. Archives of General Psychiatry, 46, 587-599.
  • CREMNITER, D., JAMAIN, S., KOLLENBACH, K., ALVAREZ, J.-C., LECRUBIER, Y., GILTON, A., JULLIEN, P., LESIEUR, P., BONNET, F. & SPREUX-VAROQUAUX, O. (1999). CSF 5-HIAA levels are lower in impulsive as compared to nonimpulsive violent suicide attempters and control subjects. B iological Psychiatry, 45, 1572-1579.
  • DAUGE, V. & LENA, I. (1998). CCK in anxiety and cognitive processes. Neuroscience & Biobehavioral Reviews, 22, 815-825.
  • DE LEO, D., CANEVA, A., MARAZZITI, D. & CONTI, L. (1991). Platelet imipramine binding in intensive care unit suicidal patients. European Archives of Psychiatry & Clinical Neuroscience, 241, 85-87.
  • EDMAN, G., ASBERG, M., LEVANDER, S. & SCHALLING, D. (1986). Skin conductance habituation and cerebrospinal fluid 5-hydroxyindoleacetic acid in suicidal patients. Archives of General Psychiatr y, 43, 586-592.
  • ENGELBERG, H. (1992). Low serum cholesterol and suicide. The Lancet, 339, 727-729.
  • ENGSTROM, G., ALSEN, M., REGNELL, G. & TRASKMAN-BENDZ, L. (1995). Serum lipids in suicide attempters. Suicide & Life-Threatening Behavior, 25, 393-400.
  • ENGSTROM, G., WESTRIN, A., EKMAN, R. & TRASKMAN-BENDZ, L. (1999). Relationships between CSF neuropeptides and temperament traits in suicide attempters. Personality & Individual Differences, 26, 13-19.
  • EVANS, J., BATTERSBY, S., OGILVIE, A.D., SMITH, C.A.D., HARMAR, A.J., NUTT, D.J. & GOODWIN, G.M. (1997). Association of short alleles of VNTR of the serotonin transporter gene with anxiety symptoms in patients presenting after deliberate self harm. Neuropharma-cology, 36, 439-443.
  • EYSENCK, H.J. (1967). The biological basis of personality. Spring eld, III: Charles C.Thomas.
  • FAUSTMAN, W.O., RINGO, D.L. & FAULL, K.F. (1993). An association between low levels of 5-HIAA and HVA in cerebrospinal fluid and early mortality in a diagnostically mixed psychiatric sample. British Journal of Psychiatry, 163, 519-521.
  • FREUD, S. (1973).Trauer und melancholie. In: A. FREUD, E. BIBRING, W. HOFFER et al. (Eds), Sigmund Freud Gesammelte Werke (pp. 428-446. Frankfurt am Main: Fischer.
  • GALLERANI, M., MANFREDINI, R., CARACCIOLO, S., SCAPOLI, C., MOLINARI, S. & FERSINI, C. (1995). Serum cholesterol concentrations in parasuicide. British Medical Journal, 310, 1632-1636.
  • GARVEY, M.J., HOLLON, S.D. & TUASON, V.B. (1994) Relationship between 3-methoxy-4-hydroxyphenylglycol and suicide. Neuropsychobiology, 29, 112-116.
  • GELERNTER, J., KRANZLER, H., COCCARO, E.F., SIEVER, L.J. & NEW, A.S. (1998). Serotonin transporter protein gene polymorphism and personality measures in African American and European American Subjects. American Journal of Psychiatry, 155, 1332-1338.
  • GLUECK, C.J., KULLER, F.E., HAMER, T., RODRIGUEZ, R., SOSA, F., SIEVESMITH, L. & MORRISON, J.A. (1994). Hypocholes-terolemia, hypertriglyceridemia, suicide, and suicide ideation in children hospitalized for psychiatric diseases. Pediatric Research, 35, 602-610.
  • GOLIER, J.A., MARZUK, P.M., LEON, A.C., WEINER, C. & TARDIFF, K. (1995). Low serum cholesterol level and attempted suicide. American Jour nal of Psychiatry, 152, 419-423.
  • GOODWIN, F.K. & JAMISON, K.R. (1990). Manic-depressive illness. New York, Oxford: Oxford University Press.
  • GRAY, J.A. (1982). The neuropsychology of anxiety: an enquiry into the functions of the septo-hippocampal system. Oxford Psychology Series. Oxford & NewYork: Clarendon Press & Oxford University Press.
  • HARRER, G. & KOFLER-WESTERGREN, B. (1986). Depression and criminality. Psychopathology, 19, 215-219.
  • HARRO, J., MARCUSSON, J. & ORELAND, L. (1992). Alternations in brain cholecystokinin receptors in suicide victims. European Neuropsychopharmacology, 2, 57-63.
  • HAWTON, K., FAGG, J. & MARSACK, P. (1980). Association between epilepsy and attempted suicide. Journal of Neurology, Neurosurgery & Psychiatry, 43, 168-170.
  • HERPERTZ, S., STEINMEYER, S.M., MARX, D., OIDTMANN, A. & SASS, H. (1995).The signi cance of aggression and impul-sivity for self-multilative behavior. Pharmacopsychiatry, 28, 64-72.
  • HIBBELN, J.R., UMHAU, J.C., LINNOILA, M., GEORGE, D.T., RAGAN, P.W., SHOAF, S.E., VAUGHAN, M.R., RAWLINGS, R. & SALEM, N. (1998). A replication study of violent and nonviolent subjects cerebrospinal fluid metabolites of serotonin and dopamine are predicted by plasma essential fatty acids. B iological Psychiatry, 44, 243-249.
  • HIGLEY, J.D. & LINNOILA, M. (1997). Low central nervous system serotonergic activity is traitlike and correlates with impulsive behavior: a nonhuman primate model investigating genetic and environmental influences on neurotransmission. Annals of the New York Academy of Sciences, 836, 39-56.
  • HIGLEY, J.D., THOMPSON, W.W., CHAMPOUX, M., GOLDMAN, D., HASERT, M.F., KRAEMER, G.W., SCANLAN, J.M., SUOMI, S.J. & LINNOILA, M. (1993). Paternal and maternal genetic and environmental contributions to cerebrospinal fluid monoamine metabolites in rhesus monkeys (Macaca mulatta). Archives of General Psychiatry, 50, 615-623.
  • HORSTEN, M., WAMALA, S.P., VINGERHOETS, A. & ORTH-GOMER, K. (1997). Depressive symptoms, social support, and lipid pro le in healthy middle-aged women. Psychosomatic Medicine, 59, 521-528.
  • HOWELLS, K. (1982). Mental disorder and violent behavior. In: P. FELDMAN (Ed.), Developments in the study of criminal behavior (pp. 163-200. New York.
  • JONSSON, B.H., UVNAS-MOBERG, K., THEORELL, T. & GOTTHARD, R. (1998). Gastrin, cholecystokinin, and somatostatin in a laboratory experiment of patients with functional dyspepsia. Psychosomatic Medicine, 60, 331-337.
  • KAPLAN, J.R., MULDOON, M.F., MANUCK, S.B. & MANN, J.J. (1997). Assessing the observed relationship between low cholesterol and violence-related mortality. Implications for suicide risk. Annals of the NewYork Academy of Sciences, 836, 57-80.
  • KAUFMAN, J., BIRMAHER, B., PEREL, J., DAHL, R.E., STULL, S., BRENT, D., TRUBNICK, L., AL-SHABBOUT, M. & RYAN, N.D. (1998). Serotonergic functioning in depressed abused children: clinical and familial correlates. B iological Psychiatry, 44, 973-981.
  • KUNUGI, H., TAKEI, N., AOKI, H. & NANKO, S. (1997). Low serum cholesterol in suicide attempters. B iological Psychiatry, 41, 196-200.
  • LESTER, D. (1995). The concentration of neurotransmitter metabolites in the cerebrospinal fluid of suicidal individuals: a meta-analysis. Pharmacopsychiatry, 28, 45-50.
  • LIDBERG, L., ASBERG, M. & SUNDQVIST-STENSMAN, U.-B. (1984). 5-hydroxyindoleacetic acid levels in attempted suicides who have killed their children. The Lancet, II, 928.
  • LIMSON, R., GOLDMAN, D., ROY, A., LAMPARSKI, D., RAVITZ, B., ADINOFF, B. & LINNOILA, M. (1991). Personality and cerebrospinal fluid monoamine metabolites in alcoholics and controls. Archives of General Psychiatry, 48, 437-441.
  • LINDBERG, G., RASTAM, L., GULLBERG, B. & EKLUND, G.A. (1992). Low serum cholesterol concentration and short term mortality from injuries in men and women [see comments]. British Medical Journal, 305, 277-279.
  • LINNOILA, M., VIRKKUNEN, M., SCHEININ, M., NUUTILA, A., RIMON, R. & GOODWIN, F.K. (1983). Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior. Life Sciences, 33, 2609-2614.
  • LOFBERG, C., AGREN, H., HARRO, J. & ORELAND, L. (1998). Cholecystokinin in CSF from depressed patients: possible relations to severity of depression and suicidal behaviour. European Neuropsychopharmacology, 8, 153-157.
  • MAES, M., COSYNS, P., MELTZER, H.Y., DEMEYER, F. & PEETERS, D. (1993). Seasonality in violent suicide but not in nonviolent suicide or homicide. American Journal of Psychiatry, 150, 1380-1385.
  • MAES, M., SMITH, R., CHRISTOPHE, A., VANDOOLAEGHE, E., VAN GASTEL, A., NEELS, H., DEMEDTS, P., WAUTERS, A. & MELTZER, H.Y. (1997). Lower serum high-density lipo-protein cholesterol (HDL-C) in major depression and in depressed men with serious suicidal attempts: relationship with immune-inflammatory markers. Acta Psychiat-rica Scandinavica, 95, 212-221.
  • MALONE, K.M., CORBITT, E.M., LI, S. & MANN, J.J. (1996). Prolactin response to fenfluramine and suicide attempt lethality in major depression. British Journal of Psychiatry, 168, 324-329.
  • MANCINI, C. & BROWN, G.M. (1992). Urinary catecho-lamines and cortisol in parasuicide. Psychiatry Research, 43, 31-42.
  • MANN, J.J. & MALONE, K.M. (1997a). Cerebrospinal fluid amines and higher-lethality suicide attempts in depressed inpatients. Biological Psychiatry, 41, 162-171.
  • MANN, J.J., MALONE, K.M., NIELSEN, D.A., GOLDMAN, D., ERDOS, J. & GELERNTER, J. (1997b). Possible association of a polymorphism of the tryptophan hydroxylase gene with suicidal behavior in depressed patients. American Journal of Psychiatry, 154, 1451-1453.
  • MANN, J.J., MCBRIDE, P.A., BROWN, R.P., LINNOILA, M., LEON, A.C., DEMEO, M., MIECZKOWSKI, T., MYERS, J.E. & STANLEY, M. (1992). Relationship between central and peripheral serotonin indexes in depressed and suicidal psychiatric inpatients. Archives of General Psychiatry, 49, 442-446.
  • MANN, J.J., STANLEY, M., MCBRIDE, P.A. & MCEWEN, B.S. (1986). Increased serotonin-2 and beta-adrenergic receptor binding in the frontal cortices of suicide victims. Archives of General Psychiatry, 43, 954-959.
  • MARAZZITI, D., DELEO, D. & CONTI, L. (1989). Further evidence supporting the role of the serotonin system in suicidal behavior: a preliminary study of suicide attempters. Acta Psychiatrica Scandinavica, 80, 322-324.
  • MARTTUNEN, M.J., ARO, H.M., HENRIKSSON, M.M. & LONNQVIST, J.K. (1994). Antisocial behaviour in adolescent suicide. Acta Psychiatrica Scandinavica, 89, 167-173.
  • MAZZANTI, C.M., LAPPALAINEN, J., LONG, J.C., BENGEL, D., NAUKKARINEN, H., EGGERT, M., VIRKKUNEN, M., LINNOILA, M. & GOLDMAN, D. (1998). Role of the serotonin transporter promoter polymorphism in anxiety-related traits. Archives of General Psychiatry, 55, 936-940.
  • MCBRIDE, P.A., BROWN, R.P., DEMEO, M., KEILP, J., MIECZ-KOWSKI, T. & MANN, J.J. (1994).The relationship of platelet 5-HT2 receptor indices to major depressive disorder, personality traits, and suicidal behavior. B iological Psychiatry, 35, 295-308.
  • MELTZER, H.Y. & ARORA, R.C. (1986). Platelet markers of suicidality. In: J.J. MANN, & M. STANLEY (Eds), Psychobi-ology of suicidal behavior (pp. 271-280. NewYork: Annals of the New York Academy of Sciences.
  • MELTZER, H.Y., PERLINE, R., TRICOU, B.J., LOWY, M. & ROBERTSON, A. (1984). Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. II. Relation to suicide, psychosis, and depressive symptoms. Archives of General Psychiatry, 41, 379-387.
  • MENDEZ, M.F. & DOSS, R.C. (1992). Ictal and psychiatric aspects of suicide in epileptic patients. International Journal of Psychiatry in Medicine, 22, 231-237.
  • MIRKIN, A.M. & COPPEN, A. (1980). Electrodermal activity in depression: clinical and biochemical correlates. British Journal of Psychiatry, 137, 93-97.
  • MODESTIN, J. & RUEF, C. (1987). Dexamethasone suppression test (DST) in relation to depressive somatic and suicidal manifestations. Acta Psychiatrica Scandinavica, 75, 491-494.
  • MOLLER, S.E., MORTENSEN, E.L., BREUM, L., ALLING, C., LARSEN, O.G., BGE-RASMUSSEN, T., JENSEN, C. & BENNICKE, K. (1996). Aggression and personality: association with amino acids and monoamine metabolites. Psychological Medicine, 26, 323-331.
  • MONTGOMERY, S.A. & MONTGOMERY, D.B. (1982). Pharmacological prevention of suicidal behavior. Journal of Affective Disorders, 4, 291-298.
  • MUCK-SELER, D., JAKOVLJEVIC, M. & PIVAC, N. (1996). Platelet 5-HT concentrations and suicidal behaviour in recurrent major depression. Journal of Affective Disorders, 39, 73-80.
  • MULDOON, M.F., KAPLAN, J.R., MANUCK, S.B. & MANN, J.J. (1992). Effects of a low-fat diet on brain serotonergic responsivity in cynomolgus monkeys. B iological Psychiatry, 31, 739-742.
  • MULDOON, M.F., MANUCK, S.B. & MATTHEWS, K.A. (1990). Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials [see comments]. British Medical Journal, 301, 309-314.
  • MULDOON, M.F., ROSSOUW, J.E., MANUCK, S.B., GLUECK, C.J., KAPLAN, J.R. & KAUFMANN, P.G. (1993). Low or lowered cholesterol and risk of death from suicide and trauma. Metabolism, 42, 45-56.
  • NEUGER, J., EL KHOURY, A., KJELLMAN, B.F., WAHLUND, B., ABERG-WISTEDT, A. & STAIN-MALMGREN, R. (1999). Platelet serotonin functions in untreated major depression. Psychiatry Research, 85, 189-198.
  • NEW, A.S., TRESTMAN, R.L., MITROPOULOU, V., BENISHAY, D.S., COCCARO, E., SILVERMAN, J. & SIEVER, L.J. (1997). Sero-tonergic function and self-injurious behavior in personality disorder patients. Psychiatry Research, 69, 17-26.
  • NIELSEN, D.A., GOLDMAN, D., VIRKKUNEN, M., TOKOLA, R., RAWLINGS, R. & LINNOILA, M. (1994). Suicidality and 5-hydroxyindoleacetic acid concentration associated with a tryptophan hydroxylase polymorphism. Archives of General Psychiatry, 51, 34-38.
  • NIELSEN, D.A., VIRKKUNEN, M., LAPPALAINEN, J., EGGERT, M., BROWN, G.L., LONG, J.C., GOLDMAN, D. & LINNOILA, M. (1998). A tryptophan hydroxylase gene marker for suicidality and alcoholism. Archives of General Psychiatry, 55, 593-602.
  • NORDSTROM, P., GUSTAVSSON, P., EDMAN, G. & ASBERG, M. (1996).Temperamental vulnerability and suicide risk after attempted suicide. Suicide & Life-Threatening Behavior, 26, 380-394.
  • NORDSTROM, P., SAMUELSSON, M., ASBERG, M., TRASKMAN-BENDZ, L., ABERG-WISTEDT, A., NORDIN, C. & BERTILSSON, L. (1994). CSF 5-HIAA predicts suicide risk after attempted suicide. Suicide & Life-Threatening Behavior, 24,1-9.
  • NORMAN, W.H., BROWN, W.A., MILLER, I.W., KEITNER, G.I. & OVERHOLSER, J.C. (1990). The dexamethasone suppression test and completed suicide. Acta Psychiatrica Scan-dinavica, 81, 120-125.
  • OHARA, K., NAGAI, M., TSUKAMOTO, T., TANI, K. & SUZUKI, Y. (1998). Functional polymorphism in the serotonin transporter promoter at the Slc6a4 locus and mood disorders. Biological Psychiatry, 44, 550-554.
  • ORDWAY, G.A., STOCKMEIER, C.A., MELTZER, H.Y., OVER-HOLSER, J.C., JACONETTA, S. & WIDDOWSON, P.S. (1995). Neuropeptidey in frontal cortex is not altered in major depression. Journal of Neurochemistry, 65, 1646-1650.
  • OSTROFF, R.B., GILLER, E., HARKNESS, L. & MASON, J. (1985). The norepinephrine-to-epinephrine ration in patients with a history of suicide attempts. American Journal of Psychiatry, 142, 224-227.
  • PANDEY, G.N., PANDEY, S.C., DWIVEDI, Y., SHARMA, R.P., JANICAK, P.G. & DAVIS, J.M. (1995). Platelet serotonin-2A receptors: a potential biological marker for suicidal behavior. American Journal of Psychiatry, 152, 850-855.
  • PANDEY, G.N., PANDEY, S.C., JANICAK, P.G., MARKS, R.C. & DAVIS, J.M. (1990). Platelet serotonin-2 receptor binding sites in depression and suicide. Biological Psychiatry, 28, 215-222.
  • PAPASSOTIROPOULOS, A., HAWELLEK, B., FRAHNERT, C., RAO, G.S. & RAO, M.L. (1999).The risk of acute suicidality in psychiatric inpatients increases with low plasma cholesterol. Pharmacopsychiatry, 32, 1-4.
  • PARTONEN, T., HAUKKA, J., VIRTAMO, J., TAYLOR, P.R. & LONNQVIST, J. (1999). Association of low serum total cholesterol with major depression and suicide. British Jour nal of Psychiatr y, 175, 259-262.
  • PAYKEL, E.S. & HENDERSON, A.J. (1977). Application of cluster analysis in the classi cation of depression. A replication study. Neuropsychobiology, 3, 111-119.
  • PERSSON, M.L., WASSERMAN, D., GEIJER, T., JONSSON, E.G. & TERENIUS, L. (1997).Tyrosine hydroxylase allelic distribution in suicide attempters. Psychiatry Research, 72, 73-80.
  • PITCHOT, W., ANSSEAU, M., GONZALEZ MORENO, A., LEMBREGHTS, M., HANSENNE, M., WAUTHY, J., REEL, C., JAMMAER, R., PAPART, P., SULON, J. & et al. (1995a). The flesinoxan 5-HT1A receptor challenge in major depression and suicidal behavior. Pharmacopsychiatry, 28, 91-92.
  • PITCHOT, W., HANSENNE, M., MORENO, A.G. & ANSSEAU, M. (1992). Suicidal behavior and growth hormone response to apomorphine test. Biological Psychiatry, 31, 1213-1219.
  • PITCHOT, W., HANSENNE, M., MORENO, A.G. & ANSSEAU, M. (1995b). The dexamethasone suppression test in violent suicide attempters with major depression. B iological Psychiatry, 37, 273-274.
  • PITCHOT, W., HANSENNE, M., MORENO, A.G. & ANSSEAU, M. (1995c). Growth hormone response to clonidine in nondepressed patients with a history of suicide attempts. Biological Psychiatry, 38, 201-203.
  • RAO, M.L., HAWELLEK, B., PAPASSOTIROPOULOS, A., DEISTER, A. & FRAHNERT, C. (1998). Upregulation of the platelet serotonin2A receptor and low blood serotonin in suicidal psychiatric patients. Neuropsychobiology, 38, 84-89.
  • RAO, M.L., MULLER-OERLINGHAUSEN, B., MACKERT, A., STREBEL, B., STIEGLITZ, R.-D. & VOLZ, H.-P. (1992). Blood serotonin, serum melatonin and light therapy in healthy subjects and in patients with nonseasonal depression. Acta Psychiatrica Scandinavica, 86, 127-132.
  • RILKE, O., SAFAR, C., ISRAEL, M., BARTH, T., FELBER, W. & OEHLER, J. (1998). Differences in whole blood serotonin levels based on a typology of parasuicide. Neuropsychobi-ology, 38, 70-72.
  • ROSENBAUM, M. (1990). The role of depression in couples involved in murder-suicide and homicide. American Journal of Psychiatry, 147, 1036-1039.
  • ROSENTHAL, N.E., DAVENPORT, Y., COWDRY, R.W., WEBSTER, M.H. & GOODWIN, F.K. (1980). Monoamine metabolites in cerebrospinal fluid of depressive subgroups. Psychiatry Research, 2, 113-119.
  • ROY, A. (1992). Hypothalamic-pituitary-adrenal axis function and suicidal behavior in depression. B iological Psychiatry, 32, 812-816.
  • ROY, A. (1993). Neuropeptides in relation to suicidal behavior in depression. Neuropsychobiology, 28, 184-186.
  • ROY, A. (1999). Suicidal behavior in depression: relationship to platelet serotonin transporter. Neuropsychobi-ology, 39, 71-75.
  • ROY, A., ADINOFF, B. & LINNOILA, M. (1988a). Acting out hostility in normal volunteers: negative correlation with levels of 5HIAA in cerebrospinal fluid. Psychiatry Research, 24, 187-194.
  • ROY, A., ADINOFF, B., ROEHRICH, L., LAMPARSKI, D., CUSTER, R., LORENZ, V., BARBACCIA, M., GUIDOTTI, A., COSTA, E. & LINNOILA, M. (1988b). Pathological gambling. A psycho-biological study. Archives of General Psychiatry, 45, 369-373.
  • ROY, A., AGREN, H., PICKAR, D., LINNOILA, M., DORAN, A.R., CUTLER, N.R. & PAUL, S.M. (1986). Reduced CSF concentrations of homovanillic acid and homovanillic acid to 5-hydroxyindoleacetic acid ratios in depressed patients: relationship to suicidal behaviour and dexam-ethasone nonsuppression. American Journal of Psychiatry, 143, 1539-1545.
  • ROY, A., DE JONG, J. & LINNOILA, M. (1989a). Cerebrospinal fluid monoamine metabolites and suicidal behavior in depressed patients. A 5-year follow-up study. Archives of General Psychiatry, 46, 609-612.
  • ROY, A., EVERETT, D., PICKAR, D. & PAUL, S.M. (1987). Platelet tritiated imipramine binding and serotonin uptake in depressed patients and controls. Relationship to plasma cortisol levels before and after dexamethasone administration. Archives of General Psychiatry, 44, 320-327.
  • ROY, A., PICKAR, D., DEJONG, J., KAROUM, F. & LINNOILA, M. (1989b). Suicidal behaviour in depression: relationship to noradrenergic function. B iological Psychiatry, 25, 341-350.
  • ROY, A., RYLANDER, G., FORSLUND, K., ASBERG, M., MAZZANTI, C., GOLDMAN, D. & NIELSEN, D. (2000). Excess TPH 17-779. allele in surviving cotwins of monozygotic twin suicide victims. Submitted for publication.
  • ROY, A., RYLANDER, G. & SARCHIAPONE, M. (1997). Genet-ices of suicide family studies and molecular genetics. In: D.M. Stoff & J.J. Mann (Eds), The neurobiology of suicide from the bench to the clinic (pp. 135-157. New York: New York Academy of Sciences.
  • ROY-BYRNE, P., POST, R.M., RUBINOW, D.R., LINNOILA, M., SAVARD, R. & DAVIS, D. (1983). CSF 5HIAA and personal and family history of suicide in affectively ill patients: a negative study. Psychiatry Research, 10, 263-274.
  • SAMUELSSON, M., NORDSTROM, P. & ASBERG, M. (1999). Suicide intent and hopelessness in the prediction of early suicide in male high risk suicide attempters, in press.
  • SCHULSINGER, F. (1980). Biological psychopathology. Annual Review of Psychiatry, 31, 583-606.
  • SCHULSINGER, F., KETY, S., ROSENTHAL, D. & WENDER, P. (1979). A family study of suicide. In: M. SCHOU & E. STROMGREN (Eds), Origin, prevention and treatment of affective disorders (pp. 277-287. London: Academic Press.
  • SEDVALL, G., FYRO, B., GULLBERG, B., NYBACK, H., WIESEL, F.A. & WODE-HELGODT, B. (1980). Relationships in healthy volunteers between concentrations of monoamine metabolites in cerebrospinal fluid and family history of psychiatric morbidity. British Journal of Psychiatr y, 136, 366-374.
  • SCHNEIDMAN, E. (1989). A multidisciplinary approach to suicide. In: D. JACOBS & H. BROWN (Eds), Suicide: understanding and responding (pp. 1-30. Madison, CT: International Universities Press.
  • SJOBRING, H. (1973). Personality: structure and development. Acta Psychiatrica Scandinavica (suppl. 244).
  • SPIGSET, O., ALLARD, P. & MJORNDAL, T. (1998). Circannual variations in the binding of [3H]lysergic acid diethyla-mide to serotonin2A receptors and of [3H]paroxetine to serotonin uptake sites in platelets from healthy volunteers. Biological Psychiatr y, 43, 774-780.
  • STANLEY, M., VIRGILIO, J. & GERSHON, S. (1982). Tritiated imipramine binding sites are decreased in frontal cortex of suicides. Science, 216, 1337-1339.
  • STRUVE, F., SARAF, K., ARHO, R., KLEIN, D. & BECHE, D. (1977). Relationship between paroxysmal electroencepha-lographic dysrhythmia and suicide ideation and attempts in psychiatric patients. In: C. SHAGASS, S. GERSHON & A. FRIEDHOFF (Eds), Psychopathology and brain dysfunction (pp. 199-221. New York: Raven Press.
  • STRUVE, F.A., KLEIN, D.F., SARAF, K.R. & OAKS, G. (1972). Electroencephalographic correlates of suicide ideation and attempts. Archives of General Psychiatry, 27, 363-365.
  • SULLIVAN, P.F., JOYCE, P.R., BULIK, C.M., MULDER, R.T. & OAKLEY-BROWNE, M. (1994). Total cholesterol and suici-dality in depression. Biological Psychiatry, 36, 472-477.
  • THORELL, L.H. (1987). Electrodermal activity in suicidal and nonsuicidal depressive patients and in matched healthy subjects. Acta Psychiatrica Scandinavica, 76, 420-430.
  • TRASKMAN, L., ASBERG, M., BERTILSSON, L. & SJOSTRAND, L. (1981). Monoamine metabolites in CSF and suicidal behavior. Archives of General Psychiatry, 38, 631-636.
  • TRASKMAN, L., TYBRING, G., ASBERG, M., BERTILSSON, L., LANTTO, O. & SCHALLING, D. (1980). Cortisol in the CSF of depressed and suicidal patients. Archives of General Psychiatry, 37, 761-767.
  • TRASKMAN-BENDZ, L., ALLING, C., ORELAND, L., REGNELL, G., VINGE, E. & OHMAN, R. (1992a). Prediction of suicidal behavior from biologic tests. Journal of Clinical Psychop-harmacology, 12, 21S 26S.
  • TRASKMAN-BENDZ, L., EKMAN, R., REGNELL, G. & OHMAN, R. (1992b). HPA-related CSF neuropeptides in suicide attempters. European Neuropsychopharmacology, 2, 99-106.
  • TRASKMAN-BENDZ, L., ASBERG, M., BERTILSSON, L. & THOREN, P. (1984). CSF monoamine metabolites of depressed patients during illness and after recovery. Acta Psychiat-rica Scandinavica, 69, 333-342.
  • UVNAS-MOBERG, K., ARN, I., JONSSON, C.O., EK, S. & NILSONNE, A. (1993). The relationships between personality traits and plasma gastrin, cholecystokinin, somatostatin, insulin, and oxytocin levels in healthy women. Journal of Psychosomatic Research, 37, 581-588.
  • VAN PRAAG, H.M. & DE HAAN, S. (1979). Central serotonin metabolism and the frequency of depression. Psychiatry Research, 1, 219-224.
  • VERKES, R.J., VAN DER MAST, R.C., KERKHOF, A.J., FEKKES, D., HENGEVELD, M.W., TUYL, J.P. & VAN KEMPEN, G.M. (1998). Platelet serotonin, monoamine oxidase activity, and [3H]paroxetine binding related to impulsive suicide attempts and borderline personality disorder. B iological Psychiatry, 43, 740-746.
  • VIRKKUNEN, M., NUUTILA, A., GOODWIN, F.K. & LINNOILA, M. (1987). Cerebrospinal fluid monoamine metabolite levels in male arsonists. Archives of General Psychiatry, 44, 241-247.
  • WESTRIN, A., EKMAN, R. & TRASKMAN-BENDZ, L. (1999). Alterations of corticotropin releasing hormone (CRH) and neuropeptideY (NPY) plasma levels in mood disorder patients with recent suicide attempt. European Neuropsychopharmacology, 9, 205-211.
  • WEISSMAN, M.M., FOX, K. & KLERMAN, G.L. (1973). Hostility and depression associated with suicide attempts. American Journal of Psychiatry, 130, 450-455.
  • WEST, D.J. (1965). Murder followed by suicide. London: Hein-emann.
  • WAGNER, A., ABERG-WISTEDT, A., ASBERG, M., EKQVIST, B., MARTENSSON, B. & MONTERO, B. (1985). Lower 3H-imipramine binding in platelets from untreated depressed patients compared to healthy controls. Psychiatry Research, 16, 131-139.
  • WESTRIN, A., ENGSTROM, G., EKMAN, R. & TRASKMAN-BENDZ, L. (1998). Correlations between plasma-neuropeptides and temperament dimensions differ between suicidal patients and healthy controls. Journal of Affective Disorders, 49, 45-54.
  • WOLFERSDORF, M. & STRAUB, R. (1994). Electrodermal reactivity in male and female depressive patients who later died by suicide. Acta Psychiatrica Scandinavica, 89, 279-284.
  • WOLFERSDORF, M., STRAUB, R., BARG, T., KELLER, F. & KASCHKA, W.P. (1999). Depressed inpatients, electro-dermal reactivity, and suicide a study about psycho-physiology of suicidal behaviour. Archives of Suicide Research, 5, 1-10.
  • WOLFERSDORF, M., STRAUB, R. & HOLE, G. (1993). Electro-dermal activity in depressive men and women with violent or non-violent suicide attempts. Schweizer Archiv fur Neurologie und Psychiatrie, 144, 173-184.
  • ZUREIK, M., COURBON, D. & DUCIMETIERE, P. (1996). Serum cholesterol concentration and death from suicide in men: Paris prospective study I [see comments]. British Medical Jour nal, 313, 649-651.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.